Dementia News and Research

Latest Dementia News and Research

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Neuroscientists at Georgetown University Medical Center say they have new evidence that challenges scientific dogma involving two fatal neurodegenerative diseases - amyotrophic lateral sclerosis (ALS), and frontotemporal dementia (FTD) - and, in the process, have uncovered a possible therapeutic target as a novel strategy to treat both disorders.

20 Dec 2012

Clock is ticking for insurance exchange implementation

The idea of a health insurance exchange as laid out in President Barack Obama's signature law seems straightforward: an online marketplace where people will shop for private health insurance, like buying an airline ticket or a hotel room.

19 Dec 2012

Calif. advocates worry court-OK'd payment reductions will make it harder for poor to get care

Some worry that a Medicaid expansion in California could be hampered by reduced payments to Medi-Cal providers that a court approved last week, making it more difficult for the poor to find specialists.

18 Dec 2012

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Blocking a single tiny blood vessel in the brain can harm neural tissue and even alter behavior, a new study from the University of California, San Diego has shown. But these consequences can be mitigated by a drug already in use, suggesting treatment that could slow the progress of dementia associated with cumulative damage to miniscule blood vessels that feed brain cells.

17 Dec 2012

Three critical illness factors independently associated with increased risk of dementia

Older people often worry about dementia and while some risks are known, for example alcoholism or stroke, the effects of illness are less clear. New research published in BioMed Central's open access journal Critical Care looks at illness requiring hospitalization and treatment in the intensive care unit (ICU) and finds that infection or severe sepsis, neurological dysfunction, such as delirium, or acute dialysis are all independently associated with an increased risk of a subsequent diagnosis of dementia.

17 Dec 2012

Cognitive test used in Alzheimer's drug trials is flawed: Study

New research led by Plymouth University Peninsula Schools of Medicine and Dentistry suggests that the cognitive test used in Alzheimer's drug trials is flawed.

16 Dec 2012

States getting arms around Medicaid expansion, challenges in own Medicaid programs

The health law's treatment of using Medicaid to expand coverage to more Americans is examined in Georgia -- where a doctor pay raise in the program has stirred discontent -- and in Oregon, where 200,000 stand to qualify under the program's expansion.

15 Dec 2012

Research provides broader understanding of processes that lead to Alzheimer's disease

Alzheimer's disease is the most common form of dementia, affecting over 35 million people worldwide. It is generally assumed that the clumping of beta-amyloid (Aβ) protein causes neuronal loss in patients.

15 Dec 2012

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

Amarantus BioScience, Inc., a biotechnology company discovering and developing treatments for diseases associated with protein misfolding and apoptosis, today announced that it has licensed the LymPro Alzheimer's Disease Diagnostic Blood Test (LymPro) from Memory Dx, LLC (MDx), formerly known as Provista Life Sciences, Inc.

14 Dec 2012

Survey finds serious shortfalls in quality of mental health care for older adults

Large majorities of older Americans with depression, anxiety, or other mental health disorders are receiving treatment that does not meet evidence-based standards, and many do not know that depression can put their health at increased risk, according to a national survey, "Silver and Blue: The Unfinished Business of Mental Health Care for Older Adults," released today by the John A. Hartford Foundation.

13 Dec 2012

Eli Lilly provides update on solanezumab Phase 3 clinical study for mild Alzheimer's

Eli Lilly and Company today provided an update on the next steps planned for solanezumab, its Phase 3 monoclonal antibody being studied as a potential therapy for patients with mild Alzheimer's disease.

13 Dec 2012

Scientists determine specific genetic switches that sync liver activity to the circadian cycle

When it's dark, and we start to fall asleep, most of us think we're tired because our bodies need rest. Yet circadian rhythms affect our bodies not just on a global scale, but at the level of individual organs, and even genes.

12 Dec 2012

Zucker Hillside Hospital celebrates opening of new $120 million inpatient pavilion

Zucker Hillside Hospital today celebrated the opening of a new 130,000-square-foot, $120 million inpatient pavilion. Constructed with the generous support of North Shore-LIJ Health System trustees Donald and Barbara Zucker and other donors, the 130,000-square-foot building will consolidate outdated living quarters dispersed across the psychiatric facility's campus, significantly improving the coordination of services and treatment along the continuum of care.

12 Dec 2012

Dementia therapy: an interview with Assoc Prof. Olivier Piguet and Sharon Savage

Dementia is the umbrella term used to describe a number of neurodegenerative brain disorders that cause progressive changes in thinking abilities and behaviour. The kind of deficits experienced by individuals diagnosed with dementia depends on the location and severity of the pathology in the brain.

11 Dec 2012

Lack of TDP-43 protein can lead to frontotemporal dementia/ALS

Researchers at Mayo Clinic in Florida have uncovered a toxic cellular process by which a protein that maintains the health of neurons becomes deficient and can lead to dementia.

11 Dec 2012

Delirium associated with higher mortality rates

A new meta-analysis has found that delirium, a condition developed by many patients in hospital intensive care units (ICU), is associated with higher mortality rates, more complications, longer stays in the ICU, and longer hospitalizations.

10 Dec 2012

Weekly telephone contact with nurses reduces hospital re-admissions for high-risk patients

Weekly telephone contact with a nurse substantially reduced hospital re-admissions for high-risk patients, according to results of a University of Wisconsin School of Medicine and Public Health (SMPH) study.

7 Dec 2012

VTT's PredictAD system promises to enable earlier diagnosis of Alzheimer's

A software tool called PredictAD developed by VTT Technical Research Centre of Finland promises to enable earlier diagnosis of the disease on the basis of patient measurements and large databases. Alzheimer's disease currently takes on average 20 months to diagnose in Europe.

4 Dec 2012

Study describes 68 cases of chronic traumatic encephalopathy in athletes, military veterans

A study done by investigators at the Boston University Center for the Study of Traumatic Encephalopathy (CSTE) and the Veterans Affairs Boston Healthcare System, in collaboration with the Sports Legacy Institute (SLI), describes 68 cases of chronic traumatic encephalopathy (CTE) among deceased athletes and military veterans whose brain and spinal cords were donated to the VA CSTE Brain Bank.

4 Dec 2012

Scientists discover new target molecule for development of treatment against Alzheimer's

Scientists from VIB and KU Leuven have discovered a new target molecule for the development of a treatment against Alzheimer's disease. There is currently no cure for this disease.

3 Dec 2012

Dementia News and Research

Latest Dementia News and Research

Scientists uncover TDP-43 protein as possible target for treatment of ALS, FTD

Clock is ticking for insurance exchange implementation

Calif. advocates worry court-OK'd payment reductions will make it harder for poor to get care

Blocking single tiny blood vessel in the brain can harm neural tissue and even alter behavior

Three critical illness factors independently associated with increased risk of dementia

Cognitive test used in Alzheimer's drug trials is flawed: Study

States getting arms around Medicaid expansion, challenges in own Medicaid programs

Research provides broader understanding of processes that lead to Alzheimer's disease

MDx, Amarantus sign license agreement for LymPro Alzheimer's disease diagnostic blood test

Survey finds serious shortfalls in quality of mental health care for older adults

Eli Lilly provides update on solanezumab Phase 3 clinical study for mild Alzheimer's

Scientists determine specific genetic switches that sync liver activity to the circadian cycle

Zucker Hillside Hospital celebrates opening of new $120 million inpatient pavilion

Dementia therapy: an interview with Assoc Prof. Olivier Piguet and Sharon Savage

Lack of TDP-43 protein can lead to frontotemporal dementia/ALS

Delirium associated with higher mortality rates

Weekly telephone contact with nurses reduces hospital re-admissions for high-risk patients

VTT's PredictAD system promises to enable earlier diagnosis of Alzheimer's

Study describes 68 cases of chronic traumatic encephalopathy in athletes, military veterans

Scientists discover new target molecule for development of treatment against Alzheimer's

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Dementia News and Research

Latest Dementia News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in